PUBLISHER: Transparency Market Research | PRODUCT CODE: 1487627
PUBLISHER: Transparency Market Research | PRODUCT CODE: 1487627
HER2 Antibodies Market (Type of Treatment Drugs: Trastuzumab, Lapatinib, Ado-trastuzumab Emtansine, Pertuzumab, and Everolimus) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2034
HER2 Antibodies Market - Scope of Report
TMR's report on the global HER2 antibodies market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global HER2 antibodies market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global HER2 antibodies market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the HER2 antibodies market.
| Market Snapshot | |
|---|---|
| Market Value in 2023 | US$ 9 Bn |
| Market Value in 2034 | US$ 15.7 Bn |
| CAGR | 5.1% |
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global HER2 antibodies market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global HER2 antibodies market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global HER2 antibodies market.
The report delves into the competitive landscape of the global HER2 antibodies market. Key players operating in the global HER2 antibodies market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global HER2 antibodies market profiled in this report.
Key Questions Answered in Global HER2 antibodies Market Report:
- What is the sales/revenue generated by HER2 antibodies across all regions during the forecast period?
- What are the opportunities in the global HER2 antibodies market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2034?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
HER2 Antibodies Market - Research Objectives and Research Approach
The comprehensive report on the global HER2 antibodies market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global HER2 antibodies market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global HER2 antibodies market.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global HER2 Antibodies Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution/Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global HER2 Antibodies Market Analysis and Forecast, 2020-2034
5. Key Insights
- 5.1. Pipeline Analysis
- 5.2. Key Product/Brand Analysis
- 5.3. Key Mergers & Acquisitions
- 5.4. COVID-19 Pandemic Impact on Industry
6. Global HER2 Antibodies Market Analysis and Forecast, by Type of Treatment Drugs
- 6.1. Introduction & Definition
- 6.2. Key Findings/Developments
- 6.3. Market Value Forecast, by Type of Treatment Drugs, 2020-2034
- 6.3.1. Trastuzumab
- 6.3.2. Lapatinib
- 6.3.3. Ado-trastuzumab Emtansine
- 6.3.4. Pertuzumab
- 6.3.5. Everolimus
- 6.4. Market Attractiveness Analysis, by Type of Treatment Drugs
7. Global HER2 Antibodies Market Analysis and Forecast, by Region
- 7.1. Key Findings
- 7.2. Market Value Forecast, by Region, 2020-2034
- 7.2.1. North America
- 7.2.2. Europe
- 7.2.3. Asia Pacific
- 7.2.4. Latin America
- 7.2.5. Middle East & Africa
- 7.3. Market Attractiveness Analysis, by Region
8. North America HER2 Antibodies Market Analysis and Forecast
- 8.1. Introduction
- 8.2. Key Findings
- 8.3. Market Value Forecast, by Type of Treatment Drugs, 2020-2034
- 8.3.1. Trastuzumab
- 8.3.2. Lapatinib
- 8.3.3. Ado-trastuzumab Emtansine
- 8.3.4. Pertuzumab
- 8.3.5. Everolimus
- 8.4. Market Value Forecast, by Country, 2020-2034
- 8.4.1. U.S.
- 8.4.2. Canada
- 8.5. Market Attractiveness Analysis
- 8.5.1. By Type of Treatment Drugs
- 8.5.2. By Country
9. Europe HER2 Antibodies Market Analysis and Forecast
- 9.1. Introduction
- 9.2. Key Findings
- 9.3. Market Value Forecast, by Type of Treatment Drugs, 2020-2034
- 9.3.1. Trastuzumab
- 9.3.2. Lapatinib
- 9.3.3. Ado-trastuzumab Emtansine
- 9.3.4. Pertuzumab
- 9.3.5. Everolimus
- 9.4. Market Value Forecast, by Country/Sub-region, 2020-2034
- 9.4.1. Germany
- 9.4.2. U.K.
- 9.4.3. France
- 9.4.4. Italy
- 9.4.5. Spain
- 9.4.6. Rest of Europe
- 9.5. Market Attractiveness Analysis
- 9.5.1. By Type of Treatment Drugs
- 9.5.2. By Country/Sub-region
10. Asia Pacific HER2 Antibodies Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Key Findings
- 10.3. Market Value Forecast, by Type of Treatment Drugs, 2020-2034
- 10.3.1. Trastuzumab
- 10.3.2. Lapatinib
- 10.3.3. Ado-trastuzumab Emtansine
- 10.3.4. Pertuzumab
- 10.3.5. Everolimus
- 10.4. Market Value Forecast, by Country/Sub-region, 2020-2034
- 10.4.1. China
- 10.4.2. Japan
- 10.4.3. India
- 10.4.4. Australia & New Zealand
- 10.4.5. Rest of Asia Pacific
- 10.5. Market Attractiveness Analysis
- 10.5.1. By Type of Treatment Drugs
- 10.5.2. By Country/Sub-region
11. Latin America HER2 Antibodies Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Key Findings
- 11.3. Market Value Forecast, by Type of Treatment Drugs, 2020-2034
- 11.3.1. Trastuzumab
- 11.3.2. Lapatinib
- 11.3.3. Ado-trastuzumab Emtansine
- 11.3.4. Pertuzumab
- 11.3.5. Everolimus
- 11.4. Market Value Forecast, by Country/Sub-region, 2020-2034
- 11.4.1. Brazil
- 11.4.2. Mexico
- 11.4.3. Rest of Latin America
- 11.5. Market Attractiveness Analysis
- 11.5.1. By Type of Treatment Drugs
- 11.5.2. By Country/Sub-region
12. Middle East & Africa HER2 Antibodies Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Key Findings
- 12.3. Market Value Forecast, by Type of Treatment Drugs, 2020-2034
- 12.3.1. Trastuzumab
- 12.3.2. Lapatinib
- 12.3.3. Ado-trastuzumab Emtansine
- 12.3.4. Pertuzumab
- 12.3.5. Everolimus
- 12.4. Market Value Forecast, by Country/Sub-region, 2020-2034
- 12.4.1. GCC Countries
- 12.4.2. South Africa
- 12.4.3. Rest of Middle East & Africa
- 12.5. Market Attractiveness Analysis
- 12.5.1. By Type of Treatment Drugs
- 12.5.2. By Country/Sub-region
13. Competition Landscape
- 13.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
- 13.2. Market Share Analysis, by Company (2023)
- 13.3. Company Profiles
- 13.3.1. Novartis AG
- 13.3.1.1. Company Overview
- 13.3.1.2. Product Portfolio
- 13.3.1.3. SWOT Analysis
- 13.3.1.4. Financial Overview
- 13.3.1.5. Strategic Overview
- 13.3.2. Pfizer, Inc.
- 13.3.2.1. Company Overview
- 13.3.2.2. Product Portfolio
- 13.3.2.3. SWOT Analysis
- 13.3.2.4. Financial Overview
- 13.3.2.5. Strategic Overview
- 13.3.3. F. Hoffmann-La Roche Ltd.
- 13.3.3.1. Company Overview
- 13.3.3.2. Product Portfolio
- 13.3.3.3. SWOT Analysis
- 13.3.3.4. Financial Overview
- 13.3.3.5. Strategic Overview
- 13.3.4. Abnova Corporation
- 13.3.4.1. Company Overview
- 13.3.4.2. Product Portfolio
- 13.3.4.3. SWOT Analysis
- 13.3.4.4. Financial Overview
- 13.3.4.5. Strategic Overview
- 13.3.5. InvivoGen
- 13.3.5.1. Company Overview
- 13.3.5.2. Product Portfolio
- 13.3.5.3. SWOT Analysis
- 13.3.5.4. Financial Overview
- 13.3.5.5. Strategic Overview
- 13.3.6. Celltrion, Inc.
- 13.3.6.1. Company Overview
- 13.3.6.2. Product Portfolio
- 13.3.6.3. SWOT Analysis
- 13.3.6.4. Financial Overview
- 13.3.6.5. Strategic Overview
- 13.3.7. Biocon
- 13.3.7.1. Company Overview
- 13.3.7.2. Product Portfolio
- 13.3.7.3. SWOT Analysis
- 13.3.7.4. Financial Overview
- 13.3.7.5. Strategic Overview
- 13.3.8. Novus Biologicals
- 13.3.8.1. Company Overview
- 13.3.8.2. Product Portfolio
- 13.3.8.3. SWOT Analysis
- 13.3.8.4. Financial Overview
- 13.3.8.5. Strategic Overview
- 13.3.1. Novartis AG
List of Tables
- Table 01: Global HER2 Antibodies Market Size (US$ Mn) Forecast, by Type of Treatment Drugs, 2020-2034
- Table 02: Global HER2 Antibodies Market Size (US$ Mn) Forecast, by Region, 2020-2034
- Table 03: North America HER2 Antibodies Market Size (US$ Mn) Forecast, by Country, 2020-2034
- Table 04: North America HER2 Antibodies Market Size (US$ Mn) Forecast, by Type of Treatment Drugs, 2020-2034
- Table 05: Europe HER2 Antibodies Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
- Table 06: Europe HER2 Antibodies Market Size (US$ Mn) Forecast, by Type of Treatment Drugs, 2020-2034
- Table 07: Asia Pacific HER2 Antibodies Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
- Table 08: Asia Pacific HER2 Antibodies Market Size (US$ Mn) Forecast, by Type of Treatment Drugs, 2020-2034
- Table 09: Latin America HER2 Antibodies Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
- Table 10: Latin America HER2 Antibodies Market Size (US$ Mn) Forecast, by Type of Treatment Drugs, 2020-2034
- Table 11: Middle East & Africa HER2 Antibodies Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
- Table 12: Middle East & Africa HER2 Antibodies Market Size (US$ Mn) Forecast, by Type of Treatment Drugs, 2020-2034
List of Figures
- Figure 01: Global HER2 Antibodies Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
- Figure 02: Global HER2 Antibodies Market Revenue (US$ Mn), by Type of Treatment Drugs, 2023
- Figure 03: Global HER2 Antibodies Market Value Share, by Type of Treatment Drugs, 2023
- Figure 04: Global HER2 Antibodies Market Value Share, by Region, 2023
- Figure 05: Global HER2 Antibodies Market Value (US$ Mn) Forecast, 2024-2034
- Figure 06: Global HER2 Antibodies Market Value Share Analysis, by Type of Treatment Drugs, 2023 and 2034
- Figure 07: Global HER2 Antibodies Market Attractiveness Analysis, by Type of Treatment Drugs, 2024-2034
- Figure 08: Global HER2 Antibodies Market Value Share Analysis, by Region, 2023 and 2034
- Figure 09: Global HER2 Antibodies Market Attractiveness Analysis, by Region, 2023-2034
- Figure 10: North America HER2 Antibodies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
- Figure 11: North America HER2 Antibodies Market Attractiveness Analysis, by Country, 2024-2034
- Figure 12: North America HER2 Antibodies Market Value Share Analysis, by Country, 2023 and 2034
- Figure 13: North America HER2 Antibodies Market Value Share Analysis, by Type of Treatment Drugs, 2023 and 2034
- Figure 14: North America HER2 Antibodies Market Attractiveness Analysis, by Type of Treatment Drugs, 2024-2034
- Figure 15: Europe HER2 Antibodies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
- Figure 16: Europe HER2 Antibodies Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
- Figure 17: Europe HER2 Antibodies Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
- Figure 18: Europe HER2 Antibodies Market Value Share Analysis, by Type of Treatment Drugs, 2023 and 2034
- Figure 19: Europe HER2 Antibodies Market Attractiveness Analysis, by Type of Treatment Drugs, 2024-2034
- Figure 20: Asia Pacific HER2 Antibodies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
- Figure 21: Asia Pacific HER2 Antibodies Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
- Figure 22: Asia Pacific HER2 Antibodies Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
- Figure 23: Asia Pacific HER2 Antibodies Market Value Share Analysis, by Type of Treatment Drugs, 2023 and 2034
- Figure 24: Asia Pacific HER2 Antibodies Market Attractiveness Analysis, by Type of Treatment Drugs, 2024-2034
- Figure 25: Latin America HER2 Antibodies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
- Figure 26: Latin America HER2 Antibodies Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
- Figure 27: Latin America HER2 Antibodies Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
- Figure 28: Latin America HER2 Antibodies Market Value Share Analysis, by Type of Treatment Drugs, 2023 and 2034
- Figure 29: Latin America HER2 Antibodies Market Attractiveness Analysis, by Type of Treatment Drugs, 2024-2034
- Figure 30: Middle East & Africa HER2 Antibodies Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
- Figure 31: Middle East & Africa HER2 Antibodies Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
- Figure 32: Middle East & Africa HER2 Antibodies Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
- Figure 33: Middle East & Africa HER2 Antibodies Market Value Share Analysis, by Type of Treatment Drugs, 2023 and 2034
- Figure 34: Middle East & Africa HER2 Antibodies Market Attractiveness Analysis, by Type of Treatment Drugs, 2024-2034
